JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,040.00
+30.00 (0.43%)
Apr 29, 2026, 9:10 AM KST
-8.21%
Market Cap 260.84B
Revenue (ttm) 76.90B
Net Income (ttm) -6.60B
Shares Out 37.21M
EPS (ttm) -184.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,329
Average Volume 405,320
Open 7,030.00
Previous Close 7,010.00
Day's Range 6,960.00 - 7,060.00
52-Week Range 5,370.00 - 11,280.00
Beta 1.05
RSI 38.58
Earnings Date May 15, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 265
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

In 2025, JETEMA,'s revenue was 76.90 billion, an increase of 12.23% compared to the previous year's 68.52 billion. Losses were -6.60 billion, 3407.4% more than in 2024.

Financial Statements

News

There is no news available yet.